Skip to content Skip to footer
U.S indices rise as jobless claims drop

U.S. Indices Rally as Jobless Claims Drop

U.S. indices continued to rally this week as markets maintained their strong start to the month of March.

Thursday’s move was assisted by data showing that Weekly Initial Jobless Claims fell to their lowest levels in 4-months.

This comes on the heels of a better-than-expected Non-Farm Payrolls number last week, where 379k jobs were added, versus 182k expected.

Whilst expected to come in at 725,000, claims for the week which ended March 6th came in at 712,000, falling by 42,000 from the previous figures.

The Dow Jones recorded a new high, with the S&P 500 also re-approaching its own ATH.

IMF warns against rate hikes

As the $1.9 trillion U.S. Stimulus package is set to be approved, the International Monetary Fund warned markets to remain cautious on the potential of rate hikes.

The IMF projects that the United States could see its economy grow by 5% to 6% over three years because of the rescue package. However, warned against the increasing of rates, which could negatively impact emerging markets.

IMF Spokesman Gerry Rice stated that the prospect of rate hikes “should be carefully managed”.

He went on to add that, “For the Federal Reserve and other central banks in advanced economies, this means continuing to communicate clearly, as they have been doing about their assessment of the economy, and their evolving views on asset purchases and interest rate policy to avoid any unwarranted tightening of financial market conditions”.

DAX 30 records new high 

Europe’s largest index the DAX 30 rallied to a new high on Thursday as it was announced that J&J’s one-shot vaccine was approved in the EU.

Related: J&J vaccine approved in U.S

The European Union confirmed the approval of the jab, which is said to have an efficacy rate of over 72%.

This now means there are over 4 vaccines in circulation, with the AstraZeneca, Pfizer, Moderna vaccines also on the table.

It was also confirmed that the EU has ordered 200 million doses, with the option for 200 million more.

The DAX closed 0.20% higher on the news.

Quote of the day – “Never invest in any idea you can’t illustrate with a crayon.”

– Peter Lynch

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.

TVM Global Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.

Tradeview Financial Markets S.A.C.

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.